456 related articles for article (PubMed ID: 33516778)
1. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer.
Park YM; Bookwalter DB; O'Brien KM; Jackson CL; Weinberg CR; Sandler DP
Ann Oncol; 2021 Mar; 32(3):351-359. PubMed ID: 33516778
[TBL] [Abstract][Full Text] [Related]
2. Metformin and other anti-diabetic medication use and breast cancer incidence in the Nurses' Health Studies.
Wang T; Chai B; Chen WY; Holmes MD; Erdrich J; Hu FB; Rosner BA; Tamimi RM; Willett WC; Kang JH; Eliassen AH
Int J Cancer; 2024 Jul; 155(2):211-225. PubMed ID: 38520039
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
Lee KN; Torres MA; Troeschel AN; He J; Gogineni K; McCullough LE
PLoS One; 2020; 15(5):e0232581. PubMed ID: 32369516
[TBL] [Abstract][Full Text] [Related]
4. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.
Calip GS; Yu O; Elmore JG; Boudreau DM
Cancer Causes Control; 2016 May; 27(5):709-20. PubMed ID: 27053250
[TBL] [Abstract][Full Text] [Related]
5. Type II Diabetes and Incidence of Estrogen Receptor Negative Breast Cancer in African American Women.
Palmer JR; Castro-Webb N; Bertrand K; Bethea TN; Denis GV
Cancer Res; 2017 Nov; 77(22):6462-6469. PubMed ID: 29141994
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
[TBL] [Abstract][Full Text] [Related]
7. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
[TBL] [Abstract][Full Text] [Related]
8. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes.
Hosio M; Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Puistola U; Läärä E; Jukkola A; Karihtala P
Breast Cancer Res Treat; 2019 Jun; 175(3):741-748. PubMed ID: 30895533
[TBL] [Abstract][Full Text] [Related]
9. Metformin and the incidence of viral associated cancers in patients with type 2 diabetes.
Hicks BM; Yin H; Sinyavskaya L; Suissa S; Azoulay L; Brassard P
Int J Cancer; 2017 Jul; 141(1):121-128. PubMed ID: 28393359
[TBL] [Abstract][Full Text] [Related]
10. Type 2 diabetes and obesity in midlife and breast cancer risk in the Reykjavik cohort.
Maskarinec G; Haraldsdóttir Á; Einarsdóttir K; Aspelund T; Tryggvadóttir L; Harris TB; Gudnason V; Torfadóttir JE
Cancer Causes Control; 2019 Oct; 30(10):1057-1065. PubMed ID: 31401707
[TBL] [Abstract][Full Text] [Related]
11. Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study.
Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Karihtala P; Jukkola A; Läärä E
Acta Oncol; 2020 Sep; 59(9):1110-1117. PubMed ID: 32478629
[No Abstract] [Full Text] [Related]
12. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study.
Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Hinkula M; Läärä E
BMC Cancer; 2018 Jul; 18(1):767. PubMed ID: 30055585
[TBL] [Abstract][Full Text] [Related]
13. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.
Vissers PA; Cardwell CR; van de Poll-Franse LV; Young IS; Pouwer F; Murray LJ
Breast Cancer Res Treat; 2015 Apr; 150(2):427-37. PubMed ID: 25762476
[TBL] [Abstract][Full Text] [Related]
14. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.
He X; Esteva FJ; Ensor J; Hortobagyi GN; Lee MH; Yeung SC
Ann Oncol; 2012 Jul; 23(7):1771-80. PubMed ID: 22112968
[TBL] [Abstract][Full Text] [Related]
15. Diabetes, metformin, and breast cancer in postmenopausal women.
Chlebowski RT; McTiernan A; Wactawski-Wende J; Manson JE; Aragaki AK; Rohan T; Ipp E; Kaklamani VG; Vitolins M; Wallace R; Gunter M; Phillips LS; Strickler H; Margolis K; Euhus DM
J Clin Oncol; 2012 Aug; 30(23):2844-52. PubMed ID: 22689798
[TBL] [Abstract][Full Text] [Related]
16. Diabetes, metformin use and risk of non-Hodgkin's lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative.
Wang Z; Phillips LS; Rohan TE; Ho GYF; Shadyab AH; Bidulescu A; Rudick CN; Pan K; Chen Z; Luo J
Int J Cancer; 2023 Apr; 152(8):1556-1569. PubMed ID: 36444502
[TBL] [Abstract][Full Text] [Related]
17. Associations between diabetes medication use and risk of second breast cancer events and mortality.
Calip GS; Yu O; Hoskins KF; Boudreau DM
Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
[TBL] [Abstract][Full Text] [Related]
18. Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes.
Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Läärä E; Karihtala P; Jukkola A
Sci Rep; 2021 May; 11(1):10445. PubMed ID: 34001921
[TBL] [Abstract][Full Text] [Related]
19. The Association of Metformin, Other Antidiabetic Medications, and Statins With the Prognosis of Colon Cancer in Patients With Type 2 Diabetes: A Retrospective Cohort Study.
Erkinantti S; Hautakoski A; Sund R; Arffman M; Urpilainen E; Puistola U; Jukkola A; Peeter K; Läärä E
Cancer Control; 2022; 29():10732748221134090. PubMed ID: 36422298
[TBL] [Abstract][Full Text] [Related]
20. Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial.
Tsilidis KK; Capothanassi D; Allen NE; Rizos EC; Lopez DS; van Veldhoven K; Sacerdote C; Ashby D; Vineis P; Tzoulaki I; Ioannidis JP
Diabetes Care; 2014 Sep; 37(9):2522-32. PubMed ID: 24898303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
